Sex Hormones and Their Receptors Regulate Liver Energy Homeostasis
Open accessThe DOI matches its Crossref record; 133 of the 135 references it cites were found in a registry or an index.
Abstract
The liver is one of the most essential organs involved in the regulation of energy homeostasis. Hepatic steatosis, a major manifestation of metabolic syndrome, is associated with imbalance between lipid formation and breakdown, glucose production and catabolism, and cholesterol synthesis and secretion. Epidemiological studies show sex difference in the prevalence in fatty liver disease and suggest that sex hormones may play vital roles in regulating hepatic steatosis. In this review, we summarize current literature and discuss the role of estrogens and androgens and the mechanisms through which estrogen receptors and androgen receptors regulate lipid and glucose metabolism in the liver. In females, estradiol regulates liver metabolism via estrogen receptors by decreasing lipogenesis, gluconeogenesis, and fatty acid uptake, while enhancing lipolysis, cholesterol secretion, and glucose catabolism. In males, testosterone works via androgen receptors to increase insulin receptor expression and glycogen synthesis, decrease glucose uptake and lipogenesis, and promote cholesterol storage in the liver. These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There is strong evidence that estrogens regulate hepatic glucose and lipid metabolism through ERs, particularly ERα (155–157).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [156]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597 · cited 1×
“Metabolic syndrome is characterized by increased visceral adiposity, hyperlipidemia, insulin resistance, and hypertension [2].”
BackgroundKuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · cited 2×
“Similar to the incidence of metabolic syndrome, the frequency of NAFLD varies between genders, with greater prevalence in men than in women among whites (42% in white men versus 24% in white women) but not in other ethnicities [10].”
BackgroundGene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
The Emergence of the Metabolic Syndrome with Menopause
Carr, M. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030242 · Cited by 1,449 · cited 1×
“menopausal women and the state of androgen deficiency as seen in aging men predispose older population to the metabolic syndrome and associated diabetes and cardiovascular diseases, indicating that sex hormones play important roles in regulating energy metabolism [5, 6].”
BackgroundDing, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
Increased adipose tissue in male and female estrogen receptor-α knockout mice
Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., & Cooke, P. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12729 · Cited by 1,282 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundThe role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136 · cited 1×
“Indeed, reduction or loss of insulin action in the liver leads to abnormally increased hepatic gluconeogenesis, glucose production, and lipogenesis, as well as decreased insulin clearance, hepatic glucose uptake, and lipolysis, consequently resulting in dyslipidemia [4].”
BackgroundSources of estrogen and their importance
Simpson, E. R. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00360-1 · Cited by 936 · cited 1×
“In premenopausal women, E2 is mainly synthesized from cholesterol in the ovaries, with E2 concentration being approximately 5 times higher than that in men, while in postmenopausal women E2 is primarily converted from testosterone by aromatase in peripheral tissues, such as adipose tissue, adrenal glands, bones, vascu…”
BackgroundFisher, C. R., Graves, K. H., Parlow, A. F., & Simpson, E. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6965 · Cited by 867 · cited 1×
“In another E2-deficient aromatase knockout (ArKO) mouse model, spontaneous obesity and hepatic steatosis result from impaired fatty acid β-oxidation and elevated fatty acid synthase (FAS) in the liver in both female and male mice [34].”
BackgroundLazo, M., Hernaez, R., Eberhardt, M. S., Bonekamp, S., Kamel, I., Guallar, E., Koteish, A., Brancati, F. L., & Clark, J. M. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws448 · Cited by 797 · cited 1×
“Nonalcoholic fatty liver disease (NAFLD) disproportionally affects people with obesity, diabetes with insulin resistance, and dyslipidemia [7–9].”
BackgroundGonadal Steroids and Body Composition, Strength, and Sexual Function in Men
Finkelstein, J. S., Lee, H., Burnett-Bowie, S.-A. M., Pallais, J. C., Yu, E. W., Borges, L. F., Jones, B. F., Barry, C. V., Wulczyn, K. E., Thomas, B. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1206168 · Cited by 782
Estrogen synthesis and signaling pathways during aging: from periphery to brain
Cui, J., Shen, Y., & Li, R. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.12.007 · Cited by 779 · cited 1×
“Epidemiological studies show sex difference in the prevalence in fatty liver disease and suggest that sex hormones may play vital roles in regulating hepatic steatosis.”
BackgroundThe Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
Lazo, M., & Clark, J. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091978 · Cited by 736 · cited 2×
“Interestingly, NAFLD is twice as common in postmenopausal women as in premenopausal women whose estrogen levels are higher than postmenopausal women [7, 11], which suggests the protective role of estrogens in NAFLD [12, 13].”
BackgroundResultAromatase-deficient (ArKO) mice have a phenotype of increased adiposity
Jones, M. E. E., Thorburn, A. W., Britt, K. L., Hewitt, K. N., Wreford, N. G., Proietto, J., Oz, O. K., Leury, B. J., Robertson, K. M., Yao, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12735 · Cited by 729
Yeh, S., & Chang, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5517 · Cited by 623
Keating, N. L., O'Malley, A. J., Freedland, S. J., & Smith, M. R. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp404 · Cited by 622 · cited 1×
“increases their risk of diabetes [112, 113] and not only increases”
BackgroundOh, J.-Y., Barrett-Connor, E., Wedick, N. M., & Wingard, D. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.55 · Cited by 594
Regulation of Sterol Synthesis in Eukaryotes
Espenshade, P. J., & Hughes, A. L. (2007) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130315 · Cited by 593
Testosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 577 · cited 3×
“Additionally, treatment of the specific ER-𝛼 agonist PPT decreases weight, fat mass, and TG in the liver in both wild-type mice and obese ob/obmice [39, 40].”
BackgroundEstrogen Regulation of Adiposity and Fuel Partitioning
D'Eon, T. M., Souza, S. C., Aronovitz, M., Obin, M. S., Fried, S. K., & Greenberg, A. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507339200 · Cited by 517
Non-genomic actions of androgens
Foradori, C. D., Weiser, M. J., & Handa, R. J. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.10.005 · Cited by 493 · cited 2×
“The nonnuclear receptor of androgens function is independent of DNA interaction and is more rapid by interacting with cytoplasmic signal transduction pathways, including PKA and MAPK/ERK [95] (Figure 1).”
BackgroundEstrogen Receptors and the Metabolic Network
Barros, R. P. A., & Gustafsson, J.-Å. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.005 · Cited by 458 · cited 1×
“A male patient without functional ER-α has been reportedwith dyslipidemia [80], supporting the importance of ER-α in regulating cholesterol homeostasis.”
BackgroundMårtensson, U. E. A., Salehi, S. A., Windahl, S., Gomez, M. F., Swärd, K., Daszkiewicz-Nilsson, J., Wendt, A., Andersson, N., Hellstrand, P., Grände, P.-O., et al. (2009) · Endocrinology · doi:10.1210/en.2008-0623 · Cited by 413 · cited 2×
“not affected [1], and glucose production in liver has not”
BackgroundWilliamson, R. M., Price, J. F., Glancy, S., Perry, E., Nee, L. D., Hayes, P. C., Frier, B. M., Van Look, L. A. F., Johnston, G. I., Reynolds, R. M., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2229 · Cited by 391
Bryzgalova, G., Gao, H., Ahren, B., Zierath, J. R., Galuska, D., Steiler, T. L., Dahlman-Wright, K., Nilsson, S., Gustafsson, J.-Å., Efendic, S., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0105-3 · Cited by 384 · cited 5×
“Male and female ER-α knockoutmice exhibit hepatic steatosis by increasing gene expression of lipogenic transcription factors such as sterol regulatory element binding protein 1c (SREBP-1c) and decreasing lipid transport genes [42, 43].”
BackgroundInfluentialType 2 diabetes mellitus and testosterone: a meta-analysis study: Type 2 diabetes and testosterone
Corona, G., Monami, M., Rastrelli, G., Aversa, A., Sforza, A., Lenzi, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01117.x · Cited by 370 · cited 1×
“circulating levels of glucose and TG in men [115].”
BackgroundTestosterone deficiency, insulin resistance and the metabolic syndrome
Zitzmann, M. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.212 · Cited by 352
Obesity and Disturbed Lipoprotein Profile in Estrogen Receptor-α-Deficient Male Mice
Ohlsson, C., Hellberg, N., Parini, P., Vidal, O., Bohlooly, M., Rudling, M., Lindberg, M. K., Warner, M., Angelin, B., & Gustafsson, J.-Å. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3827 · Cited by 332 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundZhu, L., Brown, W. C., Cai, Q., Krust, A., Chambon, P., McGuinness, O. P., & Stafford, J. M. (2013) · Diabetes · doi:10.2337/db11-1718 · Cited by 326 · cited 1×
“Mice with liver-specific ER-α knockout [44, 45] or liverspecific GPER knockout [46] show increases in fat accumulation in the liver and develop disturbed insulin signaling under high-fat diet (HFD) feeding.”
BackgroundRibas, V., Nguyen, M. T. A., Henstridge, D. C., Nguyen, A.-K., Beaven, S. W., Watt, M. J., & Hevener, A. L. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00504.2009 · Cited by 309 · cited 1×
“Additionally, treatment of the specific ER-α agonist PPT decreases weight, fat mass, and TG in the liver in both wild-type mice and obese ob/obmice [39, 40].”
BackgroundMetabolic Actions of Estrogen Receptor Beta (ERβ) are Mediated by a Negative Cross-Talk with PPARγ
Foryst-Ludwig, A., Clemenz, M., Hohmann, S., Hartge, M., Sprang, C., Frost, N., Krikov, M., Bhanot, S., Barros, R., Morani, A., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000108 · Cited by 287 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundIn vivo imaging of transcriptionally active estrogen receptors
Ciana, P., Raviscioni, M., Mussi, P., Vegeto, E., Que, I., Parker, M. G., Lowik, C., & Maggi, A. (2003) · Nature Medicine · doi:10.1038/nm809 · Cited by 286 · cited 1×
“The peak of the transcriptional activity of ER-α in the liver occurs in proestrus [26], indicating dynamics of ER-α transcriptional activity that is possibly modulated by different concentration of estrogens [27].”
BackgroundTestosterone concentrations in women and men with NIDDM
Andersson, B., Märin, P., Lissner, L., Vermeulen, A., & Björntorp, P. (1994) · Diabetes Care · doi:10.2337/diacare.17.5.405 · Cited by 268 · cited 1×
“High testosterone level is associated with a low risk of diabetes in men, whereas it is associated with a high risk of diabetes in women [111, 122–124].”
BackgroundEstrogen—the Good, the Bad, and the Unexpected
Simpson, E. R., Misso, M., Hewitt, K. N., Hill, R. A., Boon, W. C., Jones, M. E., Kovacic, A., Zhou, J., & Clyne, C. D. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0020 · Cited by 266 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundJones, H., Sprung, V. S., Pugh, C. J. A., Daousi, C., Irwin, A., Aziz, N., Adams, V. L., Thomas, E. L., Bell, J. D., Kemp, G. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1382 · Cited by 256 · cited 1×
“Although many studies have shown that androgens protect against NAFLD [50, 103], other studies have reported an opposite finding that androgens promote NAFLD development and progression [104, 105].”
BackgroundCREB-binding protein in androgen receptor-mediated signaling
Aarnisalo, P., Palvimo, J. J., & Jänne, O. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2122 · Cited by 255 · cited 1×
“Although the presence of ARE has not been identified in the promoter region of GLUT2, AR could function as a ligand-activated transcription factor by itself [117] or bind to some other coactivators [118, 119] to increase GLUT2 expression.”
BackgroundChambliss, K. L., Wu, Q., Oltmann, S., Konaniah, E. S., Umetani, M., Korach, K. S., Thomas, G. D., Mineo, C., Yuhanna, I. S., Kim, S. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38291 · Cited by 250 · cited 1×
“tein kinase (ERK) [28–30].”
Involvement of Estrogen Receptor Variant ER-α36, Not GPR30, in Nongenomic Estrogen Signaling
Kang, L., Zhang, X., Xie, Y., Tu, Y., Wang, D., Liu, Z., & Wang, Z.-Y. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0317 · Cited by 241
Altered expression of fatty acid–metabolizing enzymes in aromatase-deficient mice
Nemoto, Y., Toda, K., Ono, M., Fujikawa-Adachi, K., Saibara, T., Onishi, S., Enzan, H., Okada, T., & Shizuta, Y. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9575 · Cited by 230 · cited 1×
“Aromatase deficient mice without endogenous estrogen production exhibit obesity [79] and dyslipidemia [81] and mice with liver-specific ER-α knockout accumulate liver triglycerides and diacylglycerides [42, 43].”
BackgroundThe diversity of sex steroid action: regulation of metabolism by estrogen signaling
Faulds, M. H., Zhao, C., Dahlman-Wright, K., & Gustafsson, J.-Å. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0044 · Cited by 230
Sharma, G., Hu, C., Brigman, J. L., Zhu, G., Hathaway, H. J., & Prossnitz, E. R. (2013) · Endocrinology · doi:10.1210/en.2013-1357 · Cited by 210 · cited 12×
“Epidemiological studies have showed higher plasma level of LDL-C and lower plasma level of HDLC in men and postmenopausal women compared with premenopausal women, suggesting that lower circulating estrogen levels may promote fat deposition in the liver [32].”
BackgroundInfluentialIncreased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor
Lin, H.-Y., Yu, I.-C., Wang, R.-S., Chen, Y.-T., Liu, N.-C., Altuwaijri, S., Hsu, C.-L., Ma, W.-L., Jokinen, J., Sparks, J. D., et al. (2008) · Hepatology · doi:10.1002/hep.22252 · Cited by 209
Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats
Alvaro, D., Alpini, G., Onori, P., Perego, L., Baroni, G. S., Franchitto, A., Baiocchi, L., Glaser, S. S., Le Sage, G., Folli, F., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20184 · Cited by 196 · cited 2×
“ER-β is less abundant in liver cells than ER-α [19, 20] and GPER (unpublished observation).”
BackgroundEstrogen Replacement Reverses the Hepatic Steatosis Phenotype in the Male Aromatase Knockout Mouse
Hewitt, K. N., Pratis, K., Jones, M. E. E., & Simpson, E. R. (2004) · Endocrinology · doi:10.1210/en.2003-1369 · Cited by 188 · cited 1×
“sis that can be normalized by estrogen treatment [49].”
BackgroundEffect of Postmenopausal Hormone Therapy on Lipoprotein(a) Concentration
Espeland, M. A., Marcovina, S. M., Miller, V., Wood, P. D., Wasilauskas, C., Sherwin, R., Schrott, H., & Bush, T. L. (1998) · Circulation · doi:10.1161/01.cir.97.10.979 · Cited by 187 · cited 10×
“Epidemiological studies have showed higher plasma level of LDL-C and lower plasma level of HDLC in men and postmenopausal women compared with premenopausal women, suggesting that lower circulating estrogen levels may promote fat deposition in the liver [32].”
BackgroundInfluentialTakeda, K., Toda, K., Saibara, T., Nakagawa, M., Saika, K., Onishi, T., Sugiura, T., & Shizuta, Y. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1760237 · Cited by 182 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundTiano, J. P., Delghingaro-Augusto, V., Le May, C., Liu, S., Kaw, M. K., Khuder, S. S., Latour, M. G., Bhatt, S. A., Korach, K. S., Najjar, S. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44564 · Cited by 180
Gao, H., Bryzgalova, G., Hedman, E., Khan, A., Efendic, S., Gustafsson, J.-A., & Dahlman-Wright, K. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0012 · Cited by 179 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundMetabolic impact of estrogen signalling through ERalpha and ERbeta
Foryst-Ludwig, A., & Kintscher, U. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.06.012 · Cited by 178 · cited 1×
“These findings are further supported by previous studies demonstrating that E2 inhibits lipogenic gene expression and lipid uptake in the liver by decreasing lipoprotein lipase activity, aswell as promoting lipolysis by increasing expression of hormone-sensitive lipase and adipose TG lipase in the liver [35, 36].”
ResultRegulation and deregulation of cholesterol homeostasis: The liver as a metabolic “power station”
Trapani, L. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i6.184 · Cited by 177 · cited 1×
“Epidemiological studies have showed higher plasma level of LDL-C and lower plasma level of HDLC in men and postmenopausal women compared with premenopausal women, suggesting that lower circulating estrogen levels may promote fat deposition in the liver [32].”
BackgroundMcEwan, I. J., & Gustafsson, J.-Å. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8485 · Cited by 176 · cited 1×
“Although the presence of ARE has not been identified in the promoter region of GLUT2, AR could function as a ligand-activated transcription factor by itself [117] or bind to some other coactivators [118, 119] to increase GLUT2 expression.”
BackgroundInsulin and Leptin Resistance With Hyperleptinemia in Mice Lacking Androgen Receptor
Lin, H.-Y., Xu, Q., Yeh, S., Wang, R.-S., Sparks, J. D., & Chang, C. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1717 · Cited by 172 · cited 2×
“From the above studies, ARs are vital in regulating liver lipid homeostasis in both males and females [107], although hepatic ARs have greater impact in males than in females [102, 108].”
BackgroundA and B forms of the androgen receptor are present inhuman genital skin fibroblasts.
Wilson, C. M., & McPhaul, M. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1234 · Cited by 164 · cited 1×
“There are isoforms of ARs which are AR-A with Nterminal truncated that resulted from proteolysis and AR-B with full length [90, 91]; among these two AR isoforms, the AR-B with full length is more potent than AR-A [92].”
BackgroundSaengsirisuwan, V., Pongseeda, S., Prasannarong, M., Vichaiwong, K., & Toskulkao, C. (2008) · Metabolism · doi:10.1016/j.metabol.2008.08.004 · Cited by 153
Genome-Wide Identification of Estrogen Receptor α-Binding Sites in Mouse Liver
Gao, H., Fält, S., Sandelin, A., Gustafsson, J.-A., & Dahlman-Wright, K. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0121 · Cited by 153
Zhang, H., Liu, Y., Wang, L., Li, Z., Zhang, H., Wu, J., Rahman, N., Guo, Y., Li, D., Li, N., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m028969 · Cited by 141 · cited 18×
“Although many studies have shown that androgens protect against NAFLD [50, 103], other studies have reported an opposite finding that androgens promote NAFLD development and progression [104, 105].”
BackgroundInfluentialEstrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity
Zhu, L., Martinez, M. N., Emfinger, C. H., Palmisano, B. T., & Stafford, J. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00579.2013 · Cited by 130 · cited 1×
“Mice with liver-specific ER-α knockout [44, 45] or liverspecific GPER knockout [46] show increases in fat accumulation in the liver and develop disturbed insulin signaling under high-fat diet (HFD) feeding.”
BackgroundMohamed, M., & Abdel-Rahman, A. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420307 · Cited by 127 · cited 1×
“Liver ER-α expression does not change followingOVX; however, it significantly increases by E2 treatment at a superphysiological level in rats withOVX, higher than sham-operated ratswith intact ovaries and normal levels of endogenous estrogens [23].”
BackgroundHepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men
Völzke, H., Aumann, N., Krebs, A., Nauck, M., Steveling, A., Lerch, M. M., Rosskopf, D., & Wallaschofski, H. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.00953.x · Cited by 123 · cited 1×
“Females, as compared with males, tend to store more energy in subcutaneous fat instead of in visceral fat.”
BackgroundEstrogen Reduces Lipid Content in the Liver Exclusively from Membrane Receptor Signaling
Pedram, A., Razandi, M., O’Mahony, F., Harvey, H., Harvey, B. J., & Levin, E. R. (2013) · Science Signaling · doi:10.1126/scisignal.2004013 · Cited by 118 · cited 1×
“However, it is possible that GPER has greater impacts on male lipid regulation [54], whereas membrane-associated ER-α variant [51] may have greater impacts on female lipid regulation, as female livers have markedly higher expression of all threemembrane-associated ER-α variants compared with male livers [56].”
BackgroundHandgraaf, S., Riant, E., Fabre, A., Waget, A., Burcelin, R., Lière, P., Krust, A., Chambon, P., Arnal, J.-F., & Gourdy, P. (2013) · Diabetes · doi:10.2337/db13-0282 · Cited by 118 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundMetabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund, K. (2014) · PubMed · Cited by 117
Emerging roles of GPER in diabetes and atherosclerosis
Barton, M., & Prossnitz, E. R. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.02.003 · Cited by 114
Movérare‐Skrtic, S., Venken, K., Andersson, N., Lindberg, M. K., Svensson, J., Swanson, C., Vanderschueren, D., Oscarsson, J., Gustafsson, J., & Ohlsson, C. (2006) · Obesity · doi:10.1038/oby.2006.75 · Cited by 111 · cited 2×
“Although classic nuclear progesterone receptor has not been found in the liver [22, 66], progestins can either bind to membrane-bound progesterone receptors [67] or bind to ARs [22] in human liver and carry metabolic effects.”
BackgroundNilsson, B., Olde, B., & Leeb‐Lundberg, L. F. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01235.x · Cited by 108
Münzker, J., Hofer, D., Trummer, C., Ulbing, M., Harger, A., Pieber, T., Owen, L., Keevil, B., Brabant, G., Lerchbaum, E., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2523 · Cited by 105 · cited 13×
“ARs: Androgen receptors ARE: Androgen response element ArKO: Aromatase knockout DHT: Dihydrotestosterone E2: Estradiol ER: Estrogen receptor ER-𝛼: Estrogen receptor-𝛼 ER-𝛽: Estrogen receptor-𝛽 ERE: Estrogen response element FAS: Fatty acid synthase GPER: G protein-coupled receptor GLUT: Glucose transporter HDL-C: High…”
BackgroundInfluentialTetradian oscillation of estrogen receptor α is necessary to prevent liver lipid deposition
Villa, A., Della Torre, S., Stell, A., Cook, J., Brown, M., & Maggi, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205797109 · Cited by 101
Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Kelley, C. E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14172 · Cited by 100 · cited 1×
“Interestingly, NAFLD is twice as common in postmenopausal women as in premenopausal women whose estrogen levels are higher than postmenopausal women [7, 11], which suggests the protective role of estrogens in NAFLD [12, 13].”
BackgroundLivingstone, D. E. W., Barat, P., Di Rollo, E. M., Rees, G. A., Weldin, B. A., Rog-Zielinska, E. A., MacFarlane, D. P., Walker, B. R., & Andrew, R. (2015) · Diabetes · doi:10.2337/db14-0249 · Cited by 100 · cited 1×
“Incidence of hepatic steatosis is frequently associated with low levels of high density lipoprotein cholesterol (HDL-C) and high levels of low density lipoprotein cholesterol (LDLC) in the circulation.”
BackgroundKelly, D. M., Nettleship, J. E., Akhtar, S., Muraleedharan, V., Sellers, D. J., Brooke, J. C., McLaren, D. S., Channer, K. S., & Jones, T. H. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.06.007 · Cited by 98 · cited 2×
“[101] found that the expressions of key regulatory enzymes for fatty acid synthesis, including acetyl-CoA carboxylase (ACC) and FAS, are elevated in placebo-treated Tfm mice comparing with placebo-treated wild-type littermates and Tfm mice receiving testosterone treatment, indicating that the action of androgens on li…”
BackgroundAhmed-Sowur, H., & Bailey, C. J. (1981) · Annals of Nutrition and Metabolism · doi:10.1159/000176496 · Cited by 87 · cited 1×
“Estrogens reduce gluconeogenesis and increase glycogen synthesis and storage in the liver, lowering circulating glucose level [43, 62].”
BackgroundButler, R. K., Leigh, P. N., McPhaul, M. J., & Gallo, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.1.121 · Cited by 85 · cited 1×
“There are isoforms of ARs which are AR-A with Nterminal truncated that resulted from proteolysis and AR-B with full length [90, 91]; among these two AR isoforms, the AR-B with full length is more potent than AR-A [92].”
BackgroundThiruppathi, M., Palaniappan, M., & Balasubramanian, K. (2009) · Metabolism · doi:10.1016/j.metabol.2009.05.010 · Cited by 84 · cited 2×
“Supplementation of testosterone or a combination of testosterone with E2 normalizes GLUT2 mRNA and protein levels in the livers of castrated rats, whereas treatment of E2 alone does not have any effect [116].”
BackgroundMiceli, V., Cocciadiferro, L., Fregapane, M., Zarcone, M., Montalto, G., Polito, L. M., Agostara, B., Granata, O. M., & Carruba, G. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0108 · Cited by 83 · cited 1×
“Epidemiological studies show sex difference in the prevalence in fatty liver disease and suggest that sex hormones may play vital roles in regulating hepatic steatosis.”
BackgroundDowman, J. K., Hopkins, L. J., Reynolds, G. M., Armstrong, M. J., Nasiri, M., Nikolaou, N., van Houten, E. L. A. F., Visser, J. A., Morgan, S. A., Lavery, G. G., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1592 · Cited by 82 · cited 1×
“Liver steatosis, as seen in the nonalcoholic fatty liver disease (NAFLD), is due to the excess of triglyceride (TG) accumulation within the hepatocytes.”
BackgroundCicero, A. F. G., Tartagni, E., & Ertek, S. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.31622 · Cited by 81 · cited 1×
“Metformin, the most commonly used first-line drug to treat diabetes, is found to be effective to treat NAFLD and also suppresses the serum androgen concentration in PCOS patients [127, 128].”
BackgroundWeigt, C., Hertrampf, T., Kluxen, F. M., Flenker, U., Hülsemann, F., Fritzemeier, K. H., & Diel, P. R. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.007 · Cited by 73
Lundholm, L., Bryzgalova, G., Gao, H., Portwood, N., Fält, S., Berndt, K. D., Dicker, A., Galuska, D., Zierath, J. R., Gustafsson, J.-Å., et al. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0192 · Cited by 70
Iavarone, M., Lampertico, P., Seletti, C., Francesca Donato, M., Ronchi, G., Del Ninno, E., & Colombo, M. (2003) · Cancer · doi:10.1002/cncr.11528 · Cited by 69 · cited 1×
“Epidemiological studies show sex difference in the prevalence in fatty liver disease and suggest that sex hormones may play vital roles in regulating hepatic steatosis.”
BackgroundMaggio, M., Lauretani, F., Ceda, G. P., Bandinelli, S., Basaria, S., Paolisso, G., Ble, A., Egan, J. M., Metter, E. J., Abbatecola, A. M., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00339.2006 · Cited by 69 · cited 1×
“Estrogens are also important in hepatic insulin clearance.”
BackgroundGrossmann, M., & Zajac, J. D. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03939.x · Cited by 68 · cited 1×
“increases their risk of diabetes [112, 113] and not only increases”
BackgroundG Protein-Coupled Estrogen Receptor in Energy Homeostasis and Obesity Pathogenesis
Shi, H., Kumar, S. P. D. S., & Liu, X. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386933-3.00006-6 · Cited by 64 · cited 1×
“Estrogens act on ERs, including classic nuclear receptors ER-α and ER-β, and membrane-bound receptors, including G protein-coupled ER (GPER, also known as GPR 30) and membrane-associated ER-α and ER-β variants [15].”
BackgroundSelf-citationIntravenous estrogens increase insulin clearance and action in postmenopausal women
Van Pelt, R. E., Gozansky, W. S., Schwartz, R. S., & Kohrt, W. M. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00490.2002 · Cited by 64 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundPοlyzos, S. A., Kountouras, J., Tsatsoulis, A. A., Zafeiriadou, E., Katsiki, E., Patsiaoura, K., Zavos, C., Anastasiadou, V., & Slavakis, A. (2013) · HORMONES · doi:10.1007/bf03401306 · Cited by 64 · cited 15×
“Although many studies have shown that androgens protect against NAFLD [50, 103], other studies have reported an opposite finding that androgens promote NAFLD development and progression [104, 105].”
BackgroundInfluentialThe putative androgen receptor-A form results from in vitro proteolysis
Gregory, C., He, B., & Wilson, E. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0270309 · Cited by 63 · cited 1×
“There are isoforms of ARs which are AR-A with Nterminal truncated that resulted from proteolysis and AR-B with full length [90, 91]; among these two AR isoforms, the AR-B with full length is more potent than AR-A [92].”
BackgroundMoreno, M., Ordoñez, P., Alonso, A., Díaz, F., Tolivia, J., & González, C. (2009) · AGE · doi:10.1007/s11357-009-9095-2 · Cited by 63 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundCarulli, L., Lonardo, A., Lombardini, S., Marchesini, G., & Loria, P. (2006) · Hepatology · doi:10.1002/hep.21218 · Cited by 62
Classical Estrogen Receptors and ERα Splice Variants in the Mouse
Irsik, D. L., Carmines, P. K., & Lane, P. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070926 · Cited by 62 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
Background(2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs376 · Cited by 61
Inaba, M., Otani, Y., Nishimura, K., Takaha, N., Okuyama, Ä., Koga, M., Azuma, J., Kawase, I., & Kasayama, S. (2004) · Metabolism · doi:10.1016/j.metabol.2004.07.010 · Cited by 58 · cited 1×
“Although ER-𝛼 is antilipogenic in the liver, the role of ER-𝛽 in the liver is not consistent in the literature.”
BackgroundEstrogen receptors and androgen receptors in the mammalian liver
Eisenfeld, A. J., & Aten, R. F. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90197-x · Cited by 57 · cited 9×
“Although classic nuclear progesterone receptor has not been found in the liver [22, 66], progestins can either bind to membrane-bound progesterone receptors [67] or bind to ARs [22] in human liver and carry metabolic effects.”
BackgroundInfluentialVlahopoulos, S., Zimmer, W. E., Jenster, G., Belaguli, N. S., Balk, S. P., Brinkmann, A. O., Lanz, R. B., Zoumpourlis, V. C., & Schwartz, R. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413992200 · Cited by 55 · cited 1×
“AR can recruit other transcription factors such as AP-1, nuclear factor-κB, sex-determining region Y, and the E26 transformation-specific family of transcription factors and bind to DNA regions other than ARE, to participate in transcription activation of many other genes [94].”
BackgroundHome, P. D., & Pacini, G. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00761.x · Cited by 54 · cited 1×
“Hepatic steatosis is characterized by massive fat accumulation in the liver and thus is strongly related to several features of metabolic syndrome, including hyperlipidemia and insulin resistance [3].”
BackgroundEstradiol regulates insulin signaling and inflammation in adipose tissue
Shen, M., Kumar, S. P. D. S., & Shi, H. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0007 · Cited by 52
Self-citationHussain, Y., Ding, Q., Connelly, P. W., Brunt, J. H., Ban, M. R., McIntyre, A. D., Huff, M. W., Gros, R., Hegele, R. A., & Feldman, R. D. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304326 · Cited by 50 · cited 2×
“A recent study shows that human individuals with hypofunctional P16L genetic variant ofGPERhave increased plasma LDL [84, 85].”
BackgroundMeoli, L., Isensee, J., Zazzu, V., Nabzdyk, C. S., Soewarto, D., Witt, H., Foryst‐Ludwig, A., Kintscher, U., & Ruíz, P. (2014) · Gene · doi:10.1016/j.gene.2014.02.036 · Cited by 48 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundPleiotropic actions of estrogen: a mitochondrial matter
Velarde, M. C. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00155.2012 · Cited by 47 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundA common hypofunctional genetic variant of GPER is associated with increased blood pressure in women
Feldman, R. D., Gros, R., Ding, Q., Hussain, Y., Ban, M. R., McIntyre, A. D., & Hegele, R. A. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12471 · Cited by 46 · cited 1×
“A recent study shows that human individuals with hypofunctional P16L genetic variant ofGPERhave increased plasma LDL [84, 85].”
BackgroundCroce, L. D., Vicent, G. P., Pecci, A., Bruscalupi, G., Trentalance, A., & Beato, M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.8.0333 · Cited by 45 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundNigro, M., Santos, A. T., Barthem, C. S., Louzada, R. A. N., Fortunato, R. S., Ketzer, L. A., de Carvalho, D. P., & MEIS, L. D. (2014) · Endocrinology · doi:10.1210/en.2013-1385 · Cited by 44 · cited 3×
“Increased hepatic HMGR activity and subsequently increased levels of cholesterol and LDL are seen in rats with OVX with reduced level of endogenous estrogens [65].”
BackgroundInfluentialAndrogen Activity as a Risk Factor for Impaired Glucose Tolerance in Postmenopausal Women
Larsson, H., & Ahrén, B. (1996) · Diabetes Care · doi:10.2337/diacare.19.12.1399 · Cited by 43 · cited 1×
“Increased androgen activity in postmenopausal women correlates with impaired glucose tolerance [129, 130].”
BackgroundScheen, A. J., Jandrain, B. J., Humblet, D. M. P., Jaminet, C. B., GASPARD, U. J., & Lefèbvre, P. J. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55862-2 · Cited by 41 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundGårevik, N., Skogastierna, C., Rane, A., & Ekström, L. (2012) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-7-12 · Cited by 40 · cited 1×
“A clinical study, however, shows that a single dose of testosterone treatment increases the serum cholesterol level after two days by increasing the expression of HMGR, the rate limiting enzyme for cholesterol de novo biosynthesis in the liver, but 15 days after the testosterone administration the cholesterol levels i…”
BackgroundLemieux, C., Phaneuf, D., Labrie, F., Giguère, V., Richard, D., & Deshaies, Y. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803014 · Cited by 38
Androgen (dihydrotestosterone)–mediated regulation of food intake and obesity in female mice
Kanaya, N., Vonderfecht, S., & Chen, S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.001 · Cited by 38 · cited 13×
“ARs: Androgen receptors ARE: Androgen response element ArKO: Aromatase knockout DHT: Dihydrotestosterone E2: Estradiol ER: Estrogen receptor ER-𝛼: Estrogen receptor-𝛼 ER-𝛽: Estrogen receptor-𝛽 ERE: Estrogen response element FAS: Fatty acid synthase GPER: G protein-coupled receptor GLUT: Glucose transporter HDL-C: High…”
BackgroundInfluentialThe androgenic profile of women with non-insulin-dependent diabetes mellitus.
Tok, E. C., Ertunç, D., Evrüke, C., & Dılek, S. (2004) · PubMed · Cited by 38
Bergamini, E. (1975) · Endocrinology · doi:10.1210/endo-96-1-77 · Cited by 37 · cited 1×
“Treatment of testosterone induces glycogen synthesis in both intact and castrated male rats [108, 121].”
BackgroundEdmund Rodney, L. A. X., Tamulevicius, P., Müller, A., & Schriefers, H. J. (1983) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(83)90400-4 · Cited by 35 · cited 2×
“determines levels of ERs in male and female rat livers and reports that the levels of nuclear ERs are not sex dependent but are age dependent, as levels of ERs are similar between male and female rats and vary with the course of life in a comparable manner in males and females [21].”
BackgroundLipin1 Regulation by Estrogen in Uterus and Liver: Implications for Diabetes and Fertility
Gowri, P. M., Sengupta, S., Bertera, S., & Katzenellenbogen, B. S. (2007) · Endocrinology · doi:10.1210/en.2006-1728 · Cited by 35 · cited 1×
“Specifically, estrogens regulate the activity and expression of lipogenic genes to directly inhibit lipogenesis in several animal species [37, 38].”
BackgroundVaras, S. M., & Jahn, G. A. (2005) · Endocrine Research · doi:10.1080/07435800500454528 · Cited by 33
Targeted overexpression of androgen receptor with a liver-specific promoter in transgenic mice.
Chatterjee, B., Song, C. S., Jung, M. H., Chen, S., Walter, C. A., Herbert, D. C., Weaker, F. J., Mancini, M. A., & Roy, A. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.728 · Cited by 33 · cited 1×
“In adult rats, basal AR expression in the liver of male rats is about 20 times higher than that in the liver of female rats [87].”
BackgroundSupakar, P. C., & Roy, A. K. (1996) · Neurosignals · doi:10.1159/000109186 · Cited by 31 · cited 1×
“AR expression is also age dependent in the liver of either sex, which is very low, almost undetectable, before puberty, increases in postpubertal life, and gradually declines during aging, reaching an almost nondetectable level after about 22– 24months of age in rats [88].”
BackgroundAssociation Between Polycystic Ovary Syndrome and Metabolic Syndrome
Vélez, L. M., & Motta, A. B. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140915141030 · Cited by 30 · cited 1×
“Excess androgen in women with PCOS impairs hepatic glucose metabolism by decreasing insulin-stimulated glucose uptake and glycogen synthesis and predisposes women with PCOS to insulin resistance [125, 126].”
BackgroundLi, S., Li, Y., Ning, H., Na, L., Niu, Y., Wang, M., Feng, R., Liu, L., Guo, F., Hou, S., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.03.057 · Cited by 28 · cited 2×
“This study further demonstrates that estrogen treatment protects against increase in circulating level of cholesterol by activating of GPER [86].”
BackgroundSex steroids enhance insulin receptors and glucose oxidation in Chang liver cells
Parthasarathy, C., Renuka, V. N., & Balasubramanian, K. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.09.011 · Cited by 27 · cited 2×
“Interestingly, insulin receptor mRNA level as well as insulin sensitivity is increased in a human liver cell line when being treated with testosterone [73].”
BackgroundOestrogen improves glucose metabolism and insulin signal transduction in HepG2 cells
Xie, P., Liu, M., Yapeng, G., Lu, J., Xu, X., Zeng, W., & Song, H. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03899.x · Cited by 25 · cited 2×
“In contrast, estrogens have little effect on hepatic GLUT4 and insulin receptor in male rats, but estrogens increase level of insulin receptor in HepG2, a liver cancer cell line [72].”
BackgroundBohdanowicz-Pawlak, A., Lenarcik-Kabza, A., Brona, A., Kuliczkowska-Płaksej, J., Łaczmański, Ł., Zaleska -Dorobisz, U., & Milewicz, A. (2015) · Endokrynologia Polska · doi:10.5603/ep.2014.0058 · Cited by 24 · cited 1×
“It is noteworthy that the risk for NAFLD in women with PCOS is independent of obesity or insulin resistance but is triggered directly by the hepatotoxic, destructive effect in the liver, indicated by elevated level of alanine aminotransferase [110].”
BackgroundFeigh, M., Andreassen, K. V., Hjuler, S. T., Nielsen, R. H., Christiansen, C., Henriksen, K., & Karsdal, M. A. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31827c58ab · Cited by 22
Selmin, O., Thorne, P. A., Blachere, F. M., Johnson, P. D., & Romagnolo, D. F. (2005) · Molecular Reproduction and Development · doi:10.1002/mrd.20090 · Cited by 22
Increased leukocyte ABCA1 gene expression in post-menopausal women on hormone replacement therapy
Darabi, M., Rabbani, M., Ani, M., Zarean, E., Panjehpour, M., & Movahedian, A. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.507826 · Cited by 20 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundLinnér, C., Svartberg, J. B., Giwercman, A., & Giwercman, Y. L. (2013) · The Aging Male · doi:10.3109/13685538.2013.772134 · Cited by 16 · cited 1×
“Thus, themetabolically protective effect of estrogen may be attributed to estrogen signaling via ER-α [41].”
BackgroundWeickert, M. O., Hodges, P., Tan, B. K., & Randeva, H. S. (2012) · PubMed · doi:10.82444/warw.33696346 · Cited by 15
Roy, A. K., Vellanoweth, R. L., Chen, S., Supakar, P. C., Jung, M. H., Song, C. S., & Chatterjee, B. (1996) · Experimental Gerontology · doi:10.1016/0531-5565(95)00020-8 · Cited by 15 · cited 1×
“The sex- and age-dependent AR expression in the liver is programed by a regulatory element in the AR gene promoter [89].”
BackgroundCourtney, S., Talbot, S. T., & MANNING, R. (1988) · International Journal of Biochemistry · doi:10.1016/0020-711x(88)90013-4 · Cited by 13 · cited 1×
“These recent integrated concepts suggest that sex hormone receptors could be potential promising targets for the prevention of hepatic steatosis.”
BackgroundSchwingel, P. A., Zoppi, C. C., & Cotrim, H. P. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02552.x · Cited by 12 · cited 1×
“Although many studies have shown that androgens protect against NAFLD [50, 103], other studies have reported an opposite finding that androgens promote NAFLD development and progression [104, 105].”
Background[Hepatic regeneration in the rat after subtotal (90%) hepatectomy treated with testosterone].
Saint‐Aubert, B., Vic, P., Brissac, C., Bories, P., Humeau, C., Joyeux, H., & Solassol, C. (1980) · PubMed · Cited by 11
Magyar, Z., Békési, G., Rácz, K., Fehér, J., Schaff, Z., Lengyel, G., Blázovics, A., Íllyés, G., Szombath, D., Hrabák, A., et al. (2010) · Gerontology · doi:10.1159/000321385 · Cited by 9 · cited 15×
“Although many studies have shown that androgens protect against NAFLD [50, 103], other studies have reported an opposite finding that androgens promote NAFLD development and progression [104, 105].”
BackgroundInfluentialTHE REGULATION OF GLUCOSE PRODUCTION
Stanley, J. C. (1981) · British Journal of Anaesthesia · doi:10.1093/bja/53.2.137 · Cited by 9 · cited 1×
“Hepatic GLUT2 is upregulated by glucose, FAS, and insulin [57].”
BackgroundYamabe, N., Kang, K. S., Lee, W., Kim, S., & Zhu, B. T. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00209.2013 · Cited by 8
Jacqueson, A., Thévenin, M., Warnet, J., Claude, J., & Truhaut, R. (1978) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-66896-8_29 · Cited by 7
Effects of oestrogen on adenylate cyclase system and glucose output in rat liver
Shima, S., Okeyama, N., & AKAMATU, N. (1989) · Biochemical Journal · doi:10.1042/bj2570407 · Cited by 7 · cited 1×
“On the other hand, estrogens are also found to facilitate epinephrine’s action via β2-adrenergic receptor in regulating glycogenolysis and gluconeogenesis in the rat liver to increase circulating glucose level [68].”
Background
Research works printed but not linked: 5
- 1978, Archives of Toxicology Supplement, 193
- 1980, Comptes Rendus des Séances de l'Académie des Sciences Série D: Sciences naturelles, 291, 653
- 2004, Journal of Reproductive Medicine for the Obstetrician and Gynecologist, 49, 746
- 2014, Danish Medical Journal, 61
- 2012, Minerva Endocrinologica, 37, 25
Cited by
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
Cooke, P. S., Nanjappa, M. K., Ko, C., Prins, G. S., & Hess, R. A. (2017) · Physiological Reviews · doi:10.1152/physrev.00018.2016 · Cited by 466
Short-chain fatty acids in control of energy metabolism
Hu, J., Lin, S., Zheng, B., & Cheung, P. C. K. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1245650 · Cited by 441
Sen, P., Qadri, S., Luukkonen, P. K., Ragnarsdottir, O., McGlinchey, A., Jäntti, S., Juuti, A., Arola, J., Schlezinger, J. J., Webster, T. F., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.039 · Cited by 290
Metadata
- Authors
- Shen, M., & Shi, H.
- Affiliations
- Miami University (US)
- Corresponding author
- Shi, Haifei
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-12
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- PMC
- PMC4600502
- OpenAlex
- W2125128086
- Cited by
- 239
- References
- 135
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 29 · 2023: 27 · 2022: 22 · 2021: 23 · 2020: 23 · 2019: 20 · 2018: 16 · 2017: 20 · 2016: 16 · 2015: 1
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Endocrinology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Sigma Xi (G2012161930, G20141015719335, R15 DK090823)
- National Institutes of Health (G2012161930, G20141015719335, R15 DK090823)
- Madalene and George Shetler Diabetes Research Award (G2012161930, G20141015719335, R15 DK090823)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- sex hormones, estrogen receptor, androgen receptor, hepatic steatosis, estradiol, testosterone, lipid metabolism, glucose metabolism, gluconeogenesis, lipogenesis, cholesterol metabolism, sex differences, insulin receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.